Page 50 - Linical Workflow Optimization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical workflow optimization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Workflow Optimization Today - Breaking & Trending Today

Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints

NEW YORK CITY (dpa-AFX) - Drug major Pfizer Inc. (PFE) announced Tuesday that the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab has met its primary endpoints, having ....

Pfizer Inc , Gefallene Big Techs ,

9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome

RALEIGH, NC / ACCESSWIRE / May 30, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced ....

Bethany Sensenig , Al Medwar , Mark Sirgo , Meters Biopharma Inc View , Investor Relations Corporate Communications , Meters Biopharma Inc , Drug Administration , John Temperato , Chief Executive Officer , Chief Financial Officer , Annual Report , Quarterly Reports , Investor Relations , Inc View , Gefallene Big Techs ,

Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study

The research conducted at Cedar Clinical Research in Draper is part of the first ever phase 3 program of psilocybin therapy, and the largest of its kind
VANCOUVER, BC, May 30, 2023 /PRNewswire/ -. | May 30, 2023 ....

United States , United Kingdom , British Columbia , Paul Thielking , Cedar Clinical Research In Draper , Drug Administration , Numinus Wellness Inc , Cedar Clinical Research , Chief Science Officer , New England Journal , Guy Goodwin , Chief Medical Officer , Clinical Research , Numinus Wellness , Breakthrough Therapy , Innovative Licensing , Access Pathway , Private Securities Litigation Reform Act , Numinus Wellness Inc Stock Exchange , Press Release , 023 Numi Ca67054w1032 ,

Morphogenesis Inc.: Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology Annual Meeting

TAMPA, FL / ACCESSWIRE / May 30, 2023 / Morphogenesis, Inc. ("Morphogenesis"), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment ....

United States , Jenene Thomas , Morphogenesi Ifx , Andrew Brohl , Research Institute , H Lee Moffitt Cancer Center , Tuhura Biosciences Inc , Cohbar Inc , Morphogenesis Inc View , Morphogenesis Inc , Exchange Commission , American Society Of Clinical Oncology , Clinical Oncology , Annual Meeting , Moffitt Cancer Center , Nasdaq Capital Market , Merkel Cell Carcinoma , Information About , Proposed Transaction , Annual Report , Private Securities Litigation Reform Act , Nasdaq Capital , Gefallene Big Techs ,

AdAlta to present at June 1 Virtual Investor Summit

AdAlta Limited , the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, today announced that its CEO and Managing Director, Dr Tim Oldham, would be. | May 30, 2023 ....

Tim Oldham , Ge Healthcare , Carina Biotech Pty Ltd , Investor Summit Group , Australia Newsfile Corp , Adalta Limited , Malta Limited , Managing Director , Virtual Investor Summit , Investor Summit , Complimentary Investor , Idiopathic Pulmonary Fibrosis , Adalta Limited Stock Exchange , Press Release , Ould 1ad Au0000001ad2 ,